Literature DB >> 29654842

Optical techniques for the diagnosis and treatment of lesions induced by the human papillomavirus - A resource letter.

Natalia Mayumi Inada1, Hilde Harb Buzza1, Fernanda Mansano Carbinatto1, Kate Cristina Blanco1, Cintia Teles de Andrade2, José Dirceu Vollet-Filho3, Vanderlei Salvador Bagnato1, Ron R Allison4.   

Abstract

Human papillomaviruses (HPV) are the most common sexually-transmitted virus, and carcinogenic HPV strains are reported to be responsible for virtually all cases of cervical cancer and its precursor, the cervical intraepithelial neoplasia (CIN). About 30% of the sexually active population are considered to be affected by HPV. Around 600 million people are estimated to be infected worldwide. Diseases related to HPV cause significant impact from both the personal welfare point of view and public healthcare perspective. This resource letter collects relevant information regarding HPV-induced lesions and discusses both diagnosis and treatment, with particular attention to optical techniques and the challenges involved to the implementation of those approaches.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cervical intraepithelial neoplasia; Condyloma; HPV; PDT; Photodiagnosis; Photodynamic therapy

Mesh:

Substances:

Year:  2018        PMID: 29654842     DOI: 10.1016/j.pdpdt.2018.04.004

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  2 in total

Review 1.  Photodynamic viral inactivation: Recent advances and potential applications.

Authors:  Jace A Willis; Vsevolod Cheburkanov; Giulia Kassab; Jennifer M Soares; Kate C Blanco; Vanderlei S Bagnato; Vladislav V Yakovlev
Journal:  Appl Phys Rev       Date:  2021-06       Impact factor: 19.162

2.  DNA Biosensor Based on Double-Layer Discharge for the Detection of HPV Type 16.

Authors:  José R Espinosa; Marisol Galván; Arturo S Quiñones; Jorge L Ayala; Sergio M Durón
Journal:  Sensors (Basel)       Date:  2019-09-13       Impact factor: 3.576

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.